NCT01437722View on ClinicalTrials.gov

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

PHASE2CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2012

Conditions
Recurrent Bacterial Vaginosis (BV)
Interventions
DRUG

1% SPL7013 Gel

vaginal gel

DRUG

3% SPL7013 Gel

vaginal gel

DRUG

placebo gel

vaginal gel

All Listed Sponsors
lead

Starpharma Pty Ltd

INDUSTRY

NCT01437722 - Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV) | Biotech Hunter | Biotech Hunter